NASDAQ:GNCA

Genocea Biosciences, Inc Earning Date

USA |NASDAQ |USD

GNCA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Oct 27, 2021 Sep 2021 $-0.20 $-0.06 $-0.08
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Oct 27, 2021 Sep 2021 $0.00 $0.00 $453.00K

Genocea Biosciences, Inc's next earnings date is Wednesday, Oct 27, 2021 for the fiscal quarter ending Sep 2021.

GNCA Earnings Date & History Chart

GNCA Earnings & Revenue Forecast

GNCA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.19 $-0.21 $-0.18
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.63 $-0.67 $-0.60
Dec 2022 4 $-0.72 $-0.82 $-0.60

GNCA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.19 $-0.18 $-0.18
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.63 $-0.73 $-0.73
Dec 2022 0 / 0 $-0.72 $-0.75 $-0.75

GNCA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Dec 2022 3 $0.00 $0.00 $0.00

GNCA Earnings Date & Revenue History

GNCA Earnings History

|
Show More
Show More

GNCA Revenue History

|
Show More
Show More

Genocea Biosciences, Inc Next Earnings Date & Report

GNCA Next Earnings Date & Report Preview: Sep 2021 (FQ)

GNCA's next earnings date is Wednesday, Oct 27, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Genocea Biosciences, Inc's next quarterly earnings is $-0.20, with a low EPS estimation of $-0.22, and a high estimation of $-0.18.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.20, the last 2 month trend is $-0.19, and the 3 month trend is $-0.19.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Genocea Biosciences, Inc Previous Earnings Dates & Reports

GNCA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Genocea Biosciences, Inc's previous earnings date was Jul 29, 2021 for its fiscal quarter ended Jun 30, 2021.

GNCA's earnings per share (EPS) was $-0.06, beating the consensus analysts forecast of $-0.18 by 67.03%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -64.71%, and higher than the same period a year before (Jun 2020) by -84.62%.

Revenues were $0.00.

The company reported a net income of $-4.31M.

Free cash flow for the quarter was $-11.23M , compared to $-13.50M last quarter and $-10.23M a year before.

GNCA ended the quarter with $19.25M in total debt, a decrease of -2.01% compared to the previous quarter, and a decrease of -29.37% compared to the same quarter a year before.

GNCA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Genocea Biosciences, Inc's previous annual earnings date was Feb 11, 2021 for its fiscal year ended Dec 31, 2020.

GNCA's earnings per share (EPS) was $-1.16, missing the consensus analysts forecast of $-0.95 by 22.11% , and higher than the previous year's EPS (Dec 2019) by -48.21%.

Revenues were $1.36M.

The company reported a net income of $-43.71M.

Genocea Biosciences, Inc reported a free cash flow of $-44.24M for its fiscal year, compared to $-38.87M a year ago.

The company ended the fiscal year with $29.34M in total debt, an increase of 102.00% compared to the previous year.